Search Results | Cancer Research | American Association for Cancer Research

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Abstract 1879: CIT-801: a bifunctional anti-PD1xIL15 agent demonstrated synergy and enhanced in vivo anti-tumor efficacy

Yiwen Li, Yuxiang Hu, Welson Wang, Wei Wu

Cancer Res (2021) 81 (13_Supplement): 1879.

DOI: https://doi.org/10.1158/1538-7445.AM2021-1879

Published: 01 July 2021

View article

Journal Articles

Abstract 5571: Turning up the heat on pancreatic ductal adenocarcinoma via inhibiting vasoactive intestinal peptide signaling

Sruthi Ravindranathan, Brandon Ware, Mohammad Zaidi, Jingru Zhu, Rohan K. Dhamsania, Shuhua Wang, Yiwen Li, Ishani H. Rao, Susan N. Thomas, Gregory B. Lesinski, Bassel El-Rayes, Edmund K. Waller

Cancer Res (2020) 80 (16_Supplement): 5571.

DOI: https://doi.org/10.1158/1538-7445.AM2020-5571

Published: 15 August 2020

View article

Journal Articles

Abstract 1205: Targeting vasoactive intestinal peptide signaling to enhance pancreatic cancer responsiveness to immunotherapy

Sruthi Ravindranathan, Yiwen Li, Shuhua Wang, Mohammad Y. Zaidi, Gregory B. Lesinski, Bassel El-Rayes, Edmund K. Waller

Cancer Res (2019) 79 (13_Supplement): 1205.

DOI: https://doi.org/10.1158/1538-7445.AM2019-1205

Published: 01 July 2019

View article

Journal Articles

Abstract 2730: Preclinical characterization of the anti-PD-L1 monoclonal antibody LY3300054

Cancer Res (2018) 78 (13_Supplement): 2730.

DOI: https://doi.org/10.1158/1538-7445.AM2018-2730

Published: 01 July 2018

View article

Journal Articles

Abstract #2923: Preclinical pharmacokinetic and pharmacodynamic evaluation of the anti-FLT3 monoclonal antibody IMC-EB10

Erik Corcoran, Rajiv Bassi, Yiwen Li, David Surguladze, James Tonra

Cancer Res (2009) 69 (9_Supplement): 2923.

Published: 01 May 2009

View article

Journal Articles

Inhibition of leukemia growth by a recombinant gelonin conjugate of anti-FLT3 monoclonal antibody

Yiwen Li, Michael Rosenblum, Hongli Li, Rajiv Bassi, Wenzhi Tian, John W. Marks, Daniel Hicklin

Cancer Res (2007) 67 (9_Supplement): 4114.

Published: 01 May 2007

View article

Journal Articles

Therapeutic Implications of a Human Neutralizing Antibody to the Macrophage-Stimulating Protein Receptor Tyrosine Kinase (RON), a c-MET Family Member

Jennifer M. O'Toole, Karen E. Rabenau, Kerri Burns, Dan Lu, Venkat Mangalampalli, Paul Balderes, Nicole Covino, Rajiv Bassi, Marie Prewett, Kimberly J. Gottfredsen, Megan N. Thobe, Yuan Cheng, Yiwen Li, Daniel J. Hicklin, Zhenping Zhu, Susan E. Waltz, Michael J. Hayman, Dale L. Ludwig, Daniel S. Pereira

Cancer Res (2006) 66 (18): 9162–9170.

DOI: https://doi.org/10.1158/0008-5472.CAN-06-0283

Published: 18 September 2006

View article

Includes: Supplementary data

Journal Articles

IMC-EB10, an Anti-FLT3 Monoclonal Antibody, Prolongs Survival and Reduces Nonobese Diabetic/Severe Combined Immunodeficient Engraftment of Some Acute Lymphoblastic Leukemia Cell Lines and Primary Leukemic Samples

Obdulio Piloto, Bao Nguyen, David Huso, Kyu-Tae Kim, Yiwen Li, Larry Witte, Daniel J. Hicklin, Patrick Brown, Donald Small

Cancer Res (2006) 66 (9): 4843–4851.

DOI: https://doi.org/10.1158/0008-5472.CAN-06-0018

Published: 01 May 2006

View article

Journal Articles

Suppression of leukemia growth in vivo by a novel anti-FLT3 antibody-auristatin conjugate

Yiwen Li, Hongli Li, Mei-Nai Wang, Rajiv Bassi, Venkat Mangalampalli, Dale L. Ludwig, Paul Balderes, Larry Witte, Zhenping Zhu, Damon Meyer, Angelyn Larkin, Peter Senter, Peter Bohlen, Daniel J. Hicklin

Cancer Res (2005) 65 (9_Supplement): 1455.

Published: 01 May 2005

View article

Journal Articles

Cell-based selection of internalizing antagonistic fully human antibodies directed against FLT3 for suppression of leukemia cell growth

Brent R. Williams, Amanda Atkins, Haifan Zhang, Dan Lu, Xenia Jimenez, Hongli Li, Mei-Nai Wang, Dale Ludwig, Paul Balderes, Larry Witte, Yiwen Li, Zhenping Zhu

Cancer Res (2005) 65 (9_Supplement): 129.

Published: 01 May 2005

View article

Journal Articles

Inhibitory Anti-FLT3 Antibodies Are Capable of Mediating Antibody-Dependent Cell-Mediated Cytotoxicity and Reducing Engraftment of Acute Myelogenous Leukemia Blasts in Nonobese Diabetic/Severe Combined Immunodeficient Mice

Obdulio Piloto, Mark Levis, David Huso, Yiwen Li, Hongli Li, Mei-Nai Wang, Rajiv Bassi, Paul Balderes, Dale L. Ludwig, Larry Witte, Zhenping Zhu, Daniel J. Hicklin, Donald Small

Cancer Res (2005) 65 (4): 1514–1522.

DOI: https://doi.org/10.1158/0008-5472.CAN-04-3081

Published: 25 February 2005

View article

Journal Articles

A fully human anti-FLT3 antibody (EB10) is efficacious in leukemia models expressing either wild-type or ITD-mutant FLT3 receptor

Yiwen Li, Mei-Nai Wang, Hongli Li, Dan Lu, Rajiv Bassi, Haifan Zhang, Dale Ludwig, Paul Balderes, Obdulio Piloto, Donald Small, Larry Witte, Peter Bohlen, Zhenping Zhu, Daniel Hicklin

Cancer Res (2004) 64 (7_Supplement): 692.

Published: 01 April 2004

View article

Journal Articles

Monoclonal Antibody to Vascular Endothelial-cadherin Is a Potent Inhibitor of Angiogenesis, Tumor Growth, and Metastasis

Fang Liao, Yiwen Li, William O’Connor, Lucia Zanetta, Rajiv Bassi, Angel Santiago, Jay Overholser, Andrea Hooper, Paolo Mignatti, Elisabetta Dejana, Daniel J. Hicklin, Peter Bohlen

Cancer Res (2000) 60 (24): 6805–6810.

Published: 01 December 2000

View article

Journal Articles

Antivascular Endothelial Growth Factor Receptor (Fetal Liver Kinase 1) Monoclonal Antibody Inhibits Tumor Angiogenesis and Growth of Several Mouse and Human Tumors

Marie Prewett, James Huber, Yiwen Li, Angel Santiago, William O’Connor, Karen King, Jay Overholser, Andrea Hooper, Bronislaw Pytowski, Larry Witte, Peter Bohlen, Daniel J. Hicklin

Cancer Res (1999) 59 (20): 5209–5218.

Published: 01 October 1999

View article

NARROW

Abstract 1879: CIT-801: a bifunctional anti-PD1xIL15 agent demonstrated synergy and enhanced in vivo anti-tumor efficacy

Abstract 5571: Turning up the heat on pancreatic ductal adenocarcinoma via inhibiting vasoactive intestinal peptide signaling

Abstract 1205: Targeting vasoactive intestinal peptide signaling to enhance pancreatic cancer responsiveness to immunotherapy

Abstract 2730: Preclinical characterization of the anti-PD-L1 monoclonal antibody LY3300054

Abstract #2923: Preclinical pharmacokinetic and pharmacodynamic evaluation of the anti-FLT3 monoclonal antibody IMC-EB10

Inhibition of leukemia growth by a recombinant gelonin conjugate of anti-FLT3 monoclonal antibody

Therapeutic Implications of a Human Neutralizing Antibody to the Macrophage-Stimulating Protein Receptor Tyrosine Kinase (RON), a c-MET Family Member

IMC-EB10, an Anti-FLT3 Monoclonal Antibody, Prolongs Survival and Reduces Nonobese Diabetic/Severe Combined Immunodeficient Engraftment of Some Acute Lymphoblastic Leukemia Cell Lines and Primary Leukemic Samples

Suppression of leukemia growth in vivo by a novel anti-FLT3 antibody-auristatin conjugate

Cell-based selection of internalizing antagonistic fully human antibodies directed against FLT3 for suppression of leukemia cell growth

Inhibitory Anti-FLT3 Antibodies Are Capable of Mediating Antibody-Dependent Cell-Mediated Cytotoxicity and Reducing Engraftment of Acute Myelogenous Leukemia Blasts in Nonobese Diabetic/Severe Combined Immunodeficient Mice

A fully human anti-FLT3 antibody (EB10) is efficacious in leukemia models expressing either wild-type or ITD-mutant FLT3 receptor

Monoclonal Antibody to Vascular Endothelial-cadherin Is a Potent Inhibitor of Angiogenesis, Tumor Growth, and Metastasis

Antivascular Endothelial Growth Factor Receptor (Fetal Liver Kinase 1) Monoclonal Antibody Inhibits Tumor Angiogenesis and Growth of Several Mouse and Human Tumors

Email alerts

AACR Journals

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only